Supporting exceptional science and technology
Malin invests in and supports highly innovative life sciences companies developing exceptional science and technology to deliver transformative outcomes for patients and create significant value for shareholders.
Our purpose is to create shareholder value through the application of long-term capital and strategic support to its investee companies to enable them to reach their value potential.
Malin is headquartered in Ireland and listed on Euronext Dublin.
To deliver significant returns for our shareholders and transformative outcomes for patients by investing in and supporting highly innovative life sciences companies
4 Priority Assets
7 Growth Potential Assets
- 3 revenue generative assets
- 2 early-stage assets
- 2 public assets